A Dose Finding Study of CC-96673 in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma

Clinical trial NCT04860466 · TERMINATED

Trial details

NCT number: NCT04860466
Sponsor: Celgene
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin

Start date: 2022-01-20
Primary completion: 2024-07-31
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.